Intravitreal Ranibizumab May Induce Retinal Arteriolar Vasoconstriction in Patients with Neovascular Age-related Macular Degeneration
Authors:
- Efstratios MendrinosEMEfstratios Mendrinos
- Georgios MangiorisGMGeorgios Mangioris
- Guy DonatiGDGuy Donati
- Constantin J. PournarasCPConstantin J. Pournaras
- 1 September 2009
- journal article
- Published by Elsevier in Ophthalmology
- Vol. 116 (9) , 1755-1761
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Retinal circulatory disturbances following intracameral injection of bevacizumab for neovascular glaucomaActa Ophthalmologica, 2008
- Multiple retinal haemorrhages in diabetic retinopathy after adjunctive intravitreal bevacizumab (Avastin®) with pars plana vitrectomyActa Ophthalmologica, 2008
- Bevacizumab and Retinal IschemiaOphthalmology, 2007
- Vascular Endothelial Growth Factor-A Is a Survival Factor for Retinal Neurons and a Critical Neuroprotectant during the Adaptive Response to Ischemic InjuryThe American Journal of Pathology, 2007
- Pegaptanib and ranibizumab for neovascular age-related macular degeneration: a systematic reviewBritish Journal of Ophthalmology, 2007
- Increased Blood Pressure Induces a Diameter Response of Retinal Arterioles that Increases with Decreasing Arteriolar DiameterInvestigative Ophthalmology & Visual Science, 2007
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degenerationAmerican Journal of Ophthalmology, 2002
- Reproduzierbarkeit der Messungen mit dem Retinal Vessel Analyzer unter OptimalbedingungenKlinische Monatsblätter für Augenheilkunde, 2002
- RETINAL VESSEL ANALYZER (RVA) - DESIGN AND FUNCTIONBiomedical Engineering / Biomedizinische Technik, 2002